• Blog
  • D-dimer Testing Market Growth Analysis | 2023-2028

    D-dimer Testing Market Growth Analysis | 2023-2028

    D-dimer Testing Market Growth Analysis | 2023-2028
    Report code - SR1698 Delivery - 2 Weeks
    D-dimer Testing Market Size, Share, Trends, Forecast, & Growth Analysis - 2023-20 See more...

    Market Insights

    The D-dimer testing market was estimated at USD 1.14 billion in 2022 and is likely to grow at a CAGR of 4.60% during 2023-2028 to reach USD 1.49 billion in 2028.

    D-dimer-Testing-Market-Insights

    Wish to get a Free Sample? Register Here.

    What is D-dimer testing?

    D-dimer testing is a blood test that is performed to measure blood ability & clotting disorder. These tests are primarily consulted by doctors, during suspicion of a clotting disorder or for the diagnosis of a hemostasis system. D-Dimer is a protein fragment that has two cross-linked D fragments of protein known as fibrin that is found in a human blood sample after degradation of the blood clot by fibrinolysis. D-dimer testing is primarily used for the diagnosis of pulmonary embolism, deep vein thrombosis (DVT), and disseminated intravascular coagulation (DIC). These tests are conducted to identify the presence of D-dimer in the blood and locate any chronic clots in the body. These tests involve the emergence of monoclonal anti-D-dimer bodies with latex particles, which improves the molecular weight of the immunocomplexes in the test sample.

    Covid-19 Impact Analysis

    The outbreak of COVID-19 moderately affected the D-dimer testing industry. The healthcare industry is currently facing major challenges as it is unable to provide proper medical facilities to meet the ever-growing coronavirus patient pool. With the stringent imposition of lockdown and social distance regulations, there were limited testing and appointments for blood clots, thus affecting the market growth.

    D-dimer Testing Market Reports Overview

    Market Size in 2028

    USD 1.49 Billion

    Market Size in 2022

    USD 1.14 Billion

    Market Growth (2023-2028)

    CAGR of 4.60%

    Base Year of Study

    2022

    Trend Period

    2017-2021

    Forecast Period

    2023-2028

    Market Drivers

    The D-dimer testing market is driven by a host of factors, some of which are noted below:

    • A significant shift towards the demand for next-generation point-of-care D-dimer testing.
    • This is mainly due to the implementation of POC solutions substantially lowering waiting time, enabling faster diagnosis, reducing the length of patient stay, and leading to improved patient experience.
    • The benefits gained from these solutions in POC settings as well as the rising incidence rate of Venous Thromboembolism (VTE) along with several pulmonary & cardiovascular diseases, which causes life-threatening issues owing to blood clot formation is increasing the demand for D-dimer testing.

     

    D-dimer-Testing-Market-Dynamics

    To Get the full scope of the report, Register Here.

    Segments Analysis

    By Test Type

    The market has been divided into clinical laboratory tests and point-of-care tests. The clinical laboratory tests segment dominated the market for D-dimer testing in 2022 and accounted for a revenue share of 55% which is expected to remain dominant during the forecast period.

    Highly sensitive D-dimer assays are generally used for the exclusion of VTE as well as for the management of disseminated intravascular coagulation. Clinical laboratories have a higher frequency of tests and are well-equipped with medical facilities, thereby augmenting segment growth.

    By Application Type

    The market has been classified into deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), & others. Under these, the Deep Vein Thrombosis (DVT) segment dominated the market and accounted for a revenue share of more than 30% in 2022 and is expected to remain the largest market during the forecast period.

    DVT is a frequent medical ailment that, due to immobility, primarily affects hospitalized patients. This increases the likelihood of DVT and the risk of complications connected with it.

    Patients who have had various types of surgery are at a higher risk of acquiring DVT. According to research, patients having spinal interbody fusion are at a high risk of getting lower limb DVT. DVT also necessitates a longer hospital stay and pharmaceutical therapy that can last many months, adding to the overall healthcare expenditure. As a result, early DVT management is critical, which increases the demand for D-dimer testing on a wide scale.

    Regional Insights

    North America accounted for the largest share of more than 30% in 2022 and is expected to grow at a significant CAGR during the review period.

    The market growth is mainly propelled by well-equipped healthcare infrastructure, highly qualified medical professionals, the rising prevalence of blood clots in patients in the region, and increasing healthcare expenditure, further bolstering regional market growth.

    Asia-Pacific is expected to grow at the highest CAGR during the review on account of the growth of the major end-use industries. This growth is mainly attributed to the presence of a large patient pool in the developing economies of China and India.

    Also, the presence of supportive guidelines for coagulation tests laid down by private organizations & government bodies coupled with surging funds for healthcare facilities further proliferates the regional market expansion.

    D-Dimer-Testing-Market-Regional-Insights

    Want to know which region offers the best growth opportunities? Register Here.

    Critical Questions Answered in the Report

    • What are the key trends in the global market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global market?
    • What are the key strategies adopted by the major vendors to lead in the market?
    • What is the market share of the top vendors?

    Market Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The d-dimer testing market is segmented into the following categories.

    By Test Type

    • Clinical Laboratory Tests
    • Point-of-Care Tests

    By Application

    • Deep Vein Thrombosis (DVT)
    • Pulmonary Embolism (PE)
    • Disseminated Intravascular Coagulation (DIC)
    • Others

    By Region

    • North America (Country Analysis: The USA, Canada, and Mexico)
    • Europe (Country Analysis: Germany, France, The UK, Russia, and the Rest of Europe)
    • Asia-Pacific (Country Analysis: China, India, Australia, South Korea, and the Rest of Asia-Pacific
    • Rest of the World (Country Analysis: Saudi Arabia, Brazil, and Others)

    D-dimer-Testing-Market-Segmentation

    Want to get more details about the segmentations, Click here.

    Key Players

    The following are some of the major players operating in the D-dimer testing market are-

    • Laboratory Corporation of America Holdings (US)
    • Response Biomedical Corp (Canada)
    • Unbound Medicine, Inc (US)
    • Helena Laboratories (US)
    • Siemens Healthcare Diagnostics (US)
    • Trinity Biotech plc (Ireland)
    • Hoffmann-La Roche Ltd (Switzerland)
    • Abbott Laboratories, Inc (US)
    • Eurolyser Diagnostica GmbH (Austria)
    • ARUP Laboratories (US)

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key quest ions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the D-dimer Testing Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Target Audience

    The target audience of D-dimer testing market includes-

    • D-dimer Testing Vendors
    • D-dimer Testing Manufacturers
    • D-dimer Testing Distributors
    • Organizations
    • Government Bodies.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Customization Option

    Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    D-dimer testing is a blood test that is performed to measure blood ability & clotting disorder. These tests are primarily consulted by doctors, during suspicion of a clotting disorder or for the diagnosis of a hemostasis system. D-Dimer is a protein fragment that has two cross-linked D fragments of protein known as fibrin that is found in a human blood sample after degradation of the blood clot by fibrinolysis.

    A significant shift towards the demand for next-generation point-of-care D-dimer testing. This is mainly due to the implementation of POC solutions substantially lowering waiting time, enabling faster diagnosis, reducing the length of patient stay, and leading to improved patient experience. The benefits gained from these solutions in POC settings as well as the rising incidence rate of Venous Thromboembolism (VTE) along with several pulmonary & cardiovascular diseases, which causes life-threatening issues owing to blood clot formation is increasing the demand for D-dimer testing.

    The D-dimer testing market was estimated at USD 1.14 billion in 2022.

    The D-dimer testing market is likely to reach USD 1.49 billion in 2028.

    The D-dimer testing market is likely to grow at a CAGR of 4.60% during 2023-2028.

    D-dimer Testing Vendors, D-dimer Testing Manufacturers, D-dimer Testing Distributors, Organizations, Government Bodies are the target audience in the market.

    Laboratory Corporation of America Holdings (US), Response Biomedical Corp (Canada), Unbound Medicine, Inc (US), Helena Laboratories (US), Siemens Healthcare Diagnostics (US), Trinity Biotech plc (Ireland), Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories, Inc (US), Eurolyser Diagnostica GmbH (Austria), ARUP Laboratories (US) are among the key players in the market.

    North America accounted for the largest share of more than 30% in 2022 and is expected to grow at a significant CAGR during the review period.